1.
Teen solves centuries-old math problem
BETHESDA, Md., June 23 (UPI) -- RegeneRx Biopharmaceuticals Inc. announced a research collaboration with the U.S. Army to evaluate the efficacy of counter-chemical exposure eye drops.
U.S. company RegeneRx says it plans to collaborate with the Army Medical Research Institute of Chemical Defense and also with Gabriel Sosne, an associate professor of ophthalmology at Wayne State University.
Officials say the 12-month research collaboration is part of an effort to evaluate the ability of RGN-259 eye drops to counter the effects of a solder or security authority exposed to chemical agents.
"We are pleased to be working with U.S. military on this important project," J.J. Finkelstein, RegeneRx president and chief executive officer, said in a statement.
"We hope their work will lead to the use of our technology for treatment of eyes exposed to caustic chemicals. RegeneRx is prepared to assist in any way possible to support efforts to protect our military personnel and citizens from exposure to debilitating or life-threatening chemical agents."
|
|
|
|
|
|
| Additional Security Industry Stories | |
WASHINGTON, May 25 (UPI) --
The U.S. government called on an oil-spill response company to conduct a live drill in the Gulf of Mexico to test its capabilities, the interior secretary said.
|
LONDON, May 25 (UPI) --
Military pilot training and training aircraft were in the news this week, with European companies reaping more than $3 billion in contracts.
|
First-time buyers are driving the expectations that a recovery has begun. Their numbers and market share are growing despite financing roadblocks and competition with investors for entry-level homes. ...
|
The photos are familiar, but the captions are not, as economic tension skips across the continent of Europe.
|
| Stories | Photos | People | Comments |
View Caption
